Prospective Evaluation of Azacitidine Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

被引：0
|
作者：
Gill, Harinder [1 ]
Lie, Albert Kwok Wai [1 ]
Kwong, Yok Lam [1 ]
Leung, Anskar Y. H. [1 ]
机构：
[1] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Azacitidine maintenance after allogeneic stem cell transplantation is feasible in patients with acute myeloid leukemia and myelodysplasia
    Antar, A.
    Kharfan-Dabaja, M.
    Abou Ghaddara, H.
    Mahfouz, R.
    Bazarbachi, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S258 - S258
  • [22] Azacitidine Maintenance after Allogeneic Stem Cell Transplantation Is Feasible in Patients with Acute Myeloid Leukemia and Myelodysplasia
    Antar, Ahmad
    Kharfan-Dabaja, Mohamed A.
    Abou Ghaddara, Hussein
    Mahfouz, Rami
    Bazarbachi, Ali
    BLOOD, 2014, 124 (21)
  • [23] Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation
    Rautenberg, Christina
    Bergmann, Anika
    Germing, Ulrich
    Fischermanns, Caroline
    Pechtel, Sabrina
    Kaivers, Jennifer
    Jager, Paul
    Schuler, Esther
    Haas, Rainer
    Kobbe, Guido
    Schroeder, Thomas
    CANCERS, 2020, 12 (08) : 1 - 15
  • [24] Low-Dose Azacitidine Maintenance Therapy Post-Allogeneic Stem Cell Transplantation for High-Risk Pediatric Acute Myeloid Leukemia
    Tamura, A.
    Ishida, T.
    Saito, A.
    Yamamoto, N.
    Yokoi, T.
    Uemura, S.
    Nino, N.
    Nakamura, S.
    Kozaki, A.
    Kishimoto, K.
    Hasegawa, D.
    Kosaka, Y.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S191 - S191
  • [25] Evaluation of the Disease Risk Index on Outcomes Following Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Michelis, Fotios V.
    Messner, Hans A.
    Uhm, Jieun
    Alam, Naheed
    Loach, David
    McGillis, Laura
    Lambie, Anna
    Gupta, Vikas
    Kuruvilla, John
    Lipton, Jeffrey H.
    Seftel, Matthew D.
    Kim, Dennis D.
    BLOOD, 2014, 124 (21)
  • [26] CC-486 (Oral Azacitidine) Following Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) in Patients with Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)
    William, Basem M.
    de Lima, Marcos
    Oran, Betul
    Champlin, Richard
    Papadopoulos, Esperanza B.
    Giralt, Sergio
    Scott, Bart L.
    Hetzer, Joel
    Wang, Xiwei
    Laille, Eric
    Skikne, Barry S.
    Craddock, Charles
    BLOOD, 2014, 124 (21)
  • [27] Maintenance Therapy With Low-Dose Azacitidine After Allogeneic Hematopoietic Stem Cell Transplantation for Recurrent Acute Myelogenous Leukemia or Myelodysplastic Syndrome
    de Lima, Marcos
    Giralt, Sergio
    Thall, Peter F.
    Silva, Leandro de Padua
    Jones, Roy B.
    Komanduri, Krishna
    Braun, Thomas M.
    Nguyen, Hoang Q.
    Champlin, Richard
    Garcia-Manero, Guillermo
    CANCER, 2010, 116 (23) : 5420 - 5431
  • [28] Outcome and Prognostic Factors of High-Risk Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Zhu, Cheng-ying
    Chen, Guo-feng
    Zhou, Wei
    Hou, Cheng
    Wang, Xiao-kai
    Wang, Fei-yan
    Yang, Nan
    Wang, Li
    Fang, Shu
    Luo, Lan
    Guan, Li-xun
    Zhang, Ran
    Liu, Yu-chen
    Dou, Li-ping
    Gao, Chun-ji
    ANNALS OF TRANSPLANTATION, 2019, 24 : 328 - 340
  • [29] Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children and Adolescents with Acute Myeloid Leukemia and High-Risk Cytogenetics
    Tomizawa, D.
    Yoshida, M.
    Kondo, T.
    Miyamura, T.
    Taga, T.
    Adachi, S.
    Koh, K.
    Noguchi, M.
    Kakuda, H.
    Shiba, N.
    Watanabe, K.
    Inoue, M.
    Hashii, Y.
    Atsuta, Y.
    Ishida, H.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S85 - S86
  • [30] Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children and Adolescents with Acute Myeloid Leukemia and High-Risk Cytogenetics
    Tomizawa, D.
    Yoshida, M.
    Kondo, T.
    Miyamura, T.
    Taga, T.
    Adachi, S.
    Koh, K.
    Noguchi, M.
    Kakuda, H.
    Shiba, N.
    Watanabe, K.
    Inoue, M.
    Hashii, Y.
    Atsuta, Y.
    Ishida, H.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S192 - S193
12345